New approaches to rhesus haemolytic disease

Summary Serial assays of oestrone, oestriol, pregnanediol and chorionic gonadotrophin have been made in maternal urine from 32 weeks gestation until delivery in rhesus immunized patients whose infants suffered from haemolytic disease o varying severity. The results were compared with those from a series of normally pregnant women of comparable age and gestation period. In the rhesus patients no correlation could be demonstrated between severity of disease and endocrine profile. Assays of hormones and their metabolites were of little or no value in the management of patients with rhesus immunization.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

New approaches to rhesus haemolytic disease

Cited by 2 publications

References 16 publications

Maternal chorionic gonadotrophin concentration as an aid to the antenatal prediction of hemolytic disease of newborn infant

Maternal chorionic gonadotrophin concentration as an aid to the antenatal prediction of hemolytic disease of newborn infant

Endocrine Function in Rhesus Iso‐immunization

Contact Info

Product

Resources

About